Literature DB >> 17857024

PHEOCHROMOCYTOMA WITH DEMONSTRATION OF PRESSOR (ADRENALIN) SUBSTANCE IN THE BLOOD PREOPERATIVELY DURING HYPERTENSIVE CRISES.

E Beer, F H King, M Prinzmetal.   

Abstract

Entities:  

Year:  1937        PMID: 17857024      PMCID: PMC1390539          DOI: 10.1097/00000658-193707000-00011

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  17 in total

1.  Histological differentiation between phaeochromyocytoma and melanoma of the suprarenal gland.

Authors:  J C DICK; G M RITCHIE; H THOMPSON
Journal:  J Clin Pathol       Date:  1955-05       Impact factor: 3.411

2.  [The pheochromocytoma as a dominant hereditary dysgenetic tumor].

Authors:  C von DOEPP
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1962

3.  Pheochromocytoma.

Authors:  G F CAHILL
Journal:  Bull N Y Acad Med       Date:  1953-10

4.  Phaeochromocytoma.

Authors:  M HAMILTON; J W LITCHFIELD; W S PEART; G S C SOWRY
Journal:  Br Heart J       Date:  1953-04

5.  [Coordinated role of nerves, hormones and electrolytes in the pathophysiology of the blood pressure].

Authors:  W RAAB
Journal:  Acta Neuroveg (Wien)       Date:  1953

6.  The Circulation in Arterial Hypertension-.

Authors:  G W Pickering
Journal:  Br Med J       Date:  1943-07-10

7.  The Ocular Fundus in Pheochromocytoma of the Adrenal Gland. Report of 3 Cases.

Authors:  G M Bruce
Journal:  Trans Am Ophthalmol Soc       Date:  1947

8.  Bilateral phaeochromocytoma associated with carcinoma of the thryroid.

Authors:  U SAHAY
Journal:  Br Med J       Date:  1962-05-19

9.  A STUDY OF THE WEIGHT OF THE CELIAC GANGLION AND ITS RELATIONSHIP TO ESSENTIAL HYPERTENSION: REPORT UPON 201 CELIAC GANGLIA.

Authors:  M O Cantor
Journal:  Ann Surg       Date:  1942-03       Impact factor: 12.969

10.  ADRENAL-SYMPATHETIC SYNDROME: CHROMAFFIN TISSUE TUMOUR WITH PAROXYSMAL HYPERTENSION.

Authors:  R Mackeith
Journal:  Br Heart J       Date:  1944-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.